Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Linear IgA Bullous Dermatosis MeSH Descriptor Data 2025


MeSH Heading
Linear IgA Bullous Dermatosis
Tree Number(s)
C17.800.865.622
C20.111.585
Unique ID
D062027
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D062027
Scope Note
Autoimmune disease characterized by subepidermal blisters and linear deposition of autoantibodies at the dermoepidermal junction. The accumulated autoantibodies are of IMMUNOGLOBULIN A and occasionally IMMUNOGLOBULIN G classes against epidermal BASEMENT MEMBRANE proteins. The dermatosis is sometimes associated with malignancies and use of certain drugs (e.g., VANCOMYCIN).
Entry Term(s)
Chronic Bullous Disease of Childhood
Drug-induced Linear IgA Bullous Dermatosis
Drug-induced Linear IgA Dermatosis
Linear IgA Dermatosis
Linear IgA IgG Bullous Dermatosis
Linear IgA IgG Dermatosis
Previous Indexing
Autoimmune Diseases (1980-2012)
Skin Diseases (1980-2012)
Public MeSH Note
2013
History Note
2013
Date Established
2013/01/01
Date of Entry
2012/07/03
Revision Date
2015/10/20
Linear IgA Bullous Dermatosis Preferred
Drug-induced Linear IgA Bullous Dermatosis Narrower
Chronic Bullous Disease of Childhood Narrower
Linear IgA IgG Bullous Dermatosis Related
page delivered in 0.129s